| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | NEVRO CORP COM | 100,000 | 5,626,000 | 0.49% | Call | |
| 52 | Axovant Sciences LTD | 485,000 | 5,568,000 | 0.49% | ||
| 53 | ANTHERA PHARMACEUTICALS I | 1,492,156 | 5,402,000 | 0.47% | ||
| 54 | MYOKARDIA INC | 502,894 | 5,385,000 | 0.47% | ||
| 55 | Aldeyra Therapeutics Inc | 1,240,458 | 5,197,000 | 0.46% | ||
| 56 | CELGENE CORP | 50,000 | 5,005,000 | 0.44% | ||
| 57 | MINERVA NEUROSCIENCES INC COM | 810,537 | 4,976,000 | 0.44% | ||
| 58 | Alder Biopharmaceutl | 200,000 | 4,898,000 | 0.43% | Put | |
| 59 | ABEONA THERAPEUTICS INC | 1,762,881 | 4,512,000 | 0.40% | ||
| 60 | AMGEN INC | 30,000 | 4,498,000 | 0.39% | ||
| 61 | ONCOTHYREON INC COM N/C EFF 6/ | 3,414,121 | 4,335,000 | 0.38% | ||
| 62 | AVEXIS INC COM | 150,000 | 4,086,000 | 0.36% | ||
| 63 | GENOCEA BIOSCIENCES INC | 516,618 | 3,999,000 | 0.35% | ||
| 64 | ASSEMBLY BIOSCIENCES INC | 795,000 | 3,991,000 | 0.35% | ||
| 65 | ALCOBRA LTD | 1,028,272 | 3,897,000 | 0.34% | ||
| 66 | SPECTRANETICS CORP | 267,070 | 3,877,000 | 0.34% | ||
| 67 | ANI PHARMACEUTICALS INC | 114,060 | 3,839,000 | 0.34% | ||
| 68 | NEURODERM LTD | 270,000 | 3,812,000 | 0.33% | ||
| 69 | IMMUNOMEDICS INCORPORATED | 1,420,000 | 3,550,000 | 0.31% | ||
| 70 | Otonomy Inc | 235,986 | 3,521,000 | 0.31% | ||
| 71 | ZELTIQ AESTHETICS INC | 122,000 | 3,314,000 | 0.29% | ||
| 72 | FORWARD PHARMA A/S | 186,300 | 3,167,000 | 0.28% | ||
| 73 | AFFIMED THERAPEUTICS BV | 821,201 | 3,071,000 | 0.27% | ||
| 74 | OMEROS CORP | 200,000 | 3,068,000 | 0.27% | ||
| 75 | SUPERNUS PHARMACEUTICALS INC | 200,000 | 3,050,000 | 0.27% | ||
| 76 | WALGREENS BOOTS ALLIANCE INC | 35,292 | 2,973,000 | 0.26% | ||
| 77 | ACADIA PHARMACEUTICALS INC COM | 200,000 | 2,796,000 | 0.25% | Put | |
| 78 | TOKAI PHARMACEUTICALS INC COM | 485,338 | 2,723,000 | 0.24% | ||
| 79 | CEMPRA INC | 150,000 | 2,628,000 | 0.23% | ||
| 80 | ARDELYX INC | 315,955 | 2,455,000 | 0.22% | ||
| 81 | WAVE LIFE SCIENCES LTD | 176,000 | 2,443,000 | 0.21% | ||
| 82 | PROTEOSTASIS THERAPEUTICS IN COM | 250,000 | 2,410,000 | 0.21% | ||
| 83 | CORBUS PHARMACEUTICALS HLDGS | 1,250,000 | 2,262,000 | 0.20% | ||
| 84 | REGULUS THERAPEUTICS INC COM | 325,407 | 2,256,000 | 0.20% | ||
| 85 | UNITED THERAPEUTICS CORP DEL | 20,000 | 2,229,000 | 0.20% | ||
| 86 | Proteon Therapeutics Inc | 275,000 | 2,129,000 | 0.19% | ||
| 87 | MGC DIAGNOSTICS CORP | 336,287 | 2,045,000 | 0.18% | ||
| 88 | DEXCOM INC | 26,474 | 1,798,000 | 0.16% | ||
| 89 | EIGER BIOPHARMACEUTICALS INC | 104,920 | 1,759,000 | 0.15% | ||
| 90 | ARATANA THERAPEUTICS INC | 291,800 | 1,611,000 | 0.14% | ||
| 91 | CHINA BIOLOGIC PRODS INC | 14,000 | 1,603,000 | 0.14% | ||
| 92 | ALLIQUA BIOMEDICAL INC | 1,921,951 | 1,575,000 | 0.14% | ||
| 93 | XENON PHARMACEUTICALS INC | 205,800 | 1,438,000 | 0.13% | ||
| 94 | ARNO THERAPEUTIC INC | 3,463,292 | 1,361,000 | 0.12% | ||
| 95 | CHAMPIONS ONCOLOGY INC | 372,597 | 1,356,000 | 0.12% | ||
| 96 | DERMA SCIENCES ORD | 432,884 | 1,341,000 | 0.12% | ||
| 97 | INVITAE CORP | 118,366 | 1,211,000 | 0.11% | ||
| 98 | Agile Therapeutics, Inc. | 175,000 | 1,087,000 | 0.10% | ||
| 99 | NEOS THERAPEUTICS INC COM | 100,000 | 1,079,000 | 0.09% | ||
| 100 | BRAINSTORM CELL THERAPEUTICS | 400,000 | 1,068,000 | 0.09% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001019056-16-001336, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
